Health care stocks were mixed premarket Tuesday as the Health Care Select Sector SPDR Fund (XLV) was down a slight 0.2% and the iShares Biotechnology ETF (IBB) was recently inactive.
Humana (HUM) shares rose nearly 3% after the company reported an increase in Q4 revenue and issued a 2025 revenue outlook above analysts' expectations.
Biohaven (BHVN) shares advanced by over 7% after the company said the Food and Drug Administration accepted for priority review its new drug application for troriluzole to treat adult patients with spinocerebellar ataxia.
Royalty Pharma (RPRX) shares were down more than 0.4% after the company reported lower Q4 net income and revenue.
Comments